Exactus Announces its Hemp Seed Buyback Program to Assist Farmers Impacted by the COVID-19 Pandemic
28 mai 2020 08h00 HE
|
Exactus Inc.
DELRAY BEACH, Fla., May 28, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB: EXDI) (the “Company”) a leading supplier of hemp-derived ingredients (CBD) and feminized hemp genetics, announced today the...
Hygea and Admera Health, a CLIA Certified/CAP Accredited Laboratory, Announce Formal Partnership
26 mai 2020 09h13 HE
|
Admera Health, LLC
SAN FRANCISCO and SOUTH PLAINFIELD, N.J., May 26, 2020 (GLOBE NEWSWIRE) -- Hygea Precision Medicine (Hygea), a company focused on developing a precision medicine software system for healthcare...
CORRECTION -- Exactus, Inc. Launches a Genetics Division to Supply Farmers with USDA Compliant Feminized CBD and CBG Hemp Seeds
28 avr. 2020 10h54 HE
|
Exactus Inc.
DELRAY BEACH, Fla., April 28, 2020 (GLOBE NEWSWIRE) -- In a release issued under a similar headline today, April 28th by Exactus, Inc. (OTCQB:EXDI), please note that in the headline and opening...
Exactus, Inc. Launches a Genetics Division to Supply Farmers with FDA Compliant Feminized CBD and CBG Hemp Seeds
28 avr. 2020 08h00 HE
|
Exactus Inc.
DELRAY BEACH, Fla., April 28, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB:EXDI) (the “Company”), a leading producer of hemp and hemp-derived specialty cannabinoid products, announced today that it...
NovelStem Announces New Research Collaborations for Stem-Cell Technology Platform in Cancer Immunotherapy and COVID-19 Resistance; Reports Progress Identifying Genetic Resistance to Additional Anti-Cancer Treatments
21 avr. 2020 08h30 HE
|
NovelStem International Corp.
Screening of resistance diagnostics completed for twelve standard-of-care cancer treatments representing a significant portion of cancer treatment protocols. COVID-19 research collaboration initiated...
CENTOGENE Announces Changes in Supervisory Board
17 mars 2020 15h39 HE
|
Centogene AG
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, March 17, 2020 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world...
American Gene Technologies To Attend J.P. Morgan Healthcare Conference 2020
08 janv. 2020 08h30 HE
|
American Gene Technologies
ROCKVILLE, Md., Jan. 08, 2020 (GLOBE NEWSWIRE) -- American Gene Technologies announced today that its Chief Executive Officer, Jeff Galvin, will attend the 38th annual J.P. Morgan Healthcare...
BioReference Laboratories Showcases 2019 Growth through the Addition of Cutting Edge Tests, Greater Access to Services, and Optimized Patient Experience
19 déc. 2019 12h00 HE
|
Bio-Reference Laboratories
Elmwood Park, NJ, Dec. 19, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, Inc., and oncology, urology and...
Definitive Research Study Shows Genes Contribute Only 5-10% to a Person’s Chance of Developing a Disease
18 déc. 2019 08h00 HE
|
Molecular You Corporation
VANCOUVER, British Columbia, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Molecular You Corp announces the publication of a new research study led by one of its chief scientists, Dr. David Wishart, which...
Segra enters into Strategic Plant Genotyping and Tissue Culture Agreement with Sugarbud
05 déc. 2019 16h57 HE
|
Segra International Corp.
VANCOUVER, British Columbia, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Segra International Corp. ("Segra") is pleased to announce that it has entered into a strategic plant genotyping and tissue culture...